Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version
Leuk Lymphoma
.
2020 Dec;61(14):3498-3502.
doi: 10.1080/10428194.2020.1808212.
Epub 2020 Sep 2.
Authors
Jiwon Yun
1
,
Jung-Ah Kim
1
,
Junseo Park
2
,
Kyongok Im
3
,
Young Eun Lee
1
,
Dajeong Jeong
1
,
Sohee Ryu
1
,
Kyu Min Lim
4
,
Sung-Min Kim
4
,
Yong-Oon Ahn
4
5
,
Dong Soon Lee
1
4
Affiliations
1
Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
2
The Webb Schools, Claremont, CA, USA.
3
Institute of Reproductive Medicine and Population Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea.
4
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
5
Medical Research Center, Seoul National University, Seoul, Republic of Korea.
PMID:
32876501
DOI:
10.1080/10428194.2020.1808212
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Myeloproliferative Disorders* / diagnosis
Myeloproliferative Disorders* / genetics
Philadelphia Chromosome
Polycythemia Vera*
World Health Organization